Oryzon Genomics S.A. (BME:ORY)
2.820
-0.020 (-0.70%)
Aug 27, 2026, 5:35 PM CET
Oryzon Genomics Employees
Oryzon Genomics had 46 employees as of June 30, 2026. The number of employees did not change since the number was reported on December 31, 2025.
Employees
46
Change
n/a
Growth
n/a
Revenue / Employee
€334,939
Profits / Employee
€52,791
Market Cap
231.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 46 | 0 | - |
| Dec 31, 2025 | 46 | -1 | -2.13% |
| Dec 31, 2024 | 47 | 1 | 2.17% |
| Dec 31, 2023 | 46 | 2 | 4.78% |
| Dec 31, 2022 | 44 | 0 | - |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Grifols | 25,000 |
| Laboratorios Farmaceuticos Rovi | 2,470 |
| Almirall | 2,097 |
| Clínica Baviera | 2,009 |
| Laboratorio Reig Jofre | 1,400 |
| Prim, S.A. | 959 |
| Atrys Health | 758 |
| Pharma Mar | 505 |
Oryzon Genomics News
- 4 weeks ago - Oryzon Genomics Earnings release: Q2 2026 - Filings
- 3 months ago - Oryzon Genomics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 3 months ago - ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026 - GlobeNewsWire
- 3 months ago - Oryzon Genomics Earnings release: Q1 2026 - Filings
- 3 months ago - ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026 - GlobeNewsWire
- 6 months ago - Oryzon Genomics announces patent grant decision in Mexico - TheFly
- 6 months ago - Oryzon Genomics Slides: Corporate presentation - Filings
- 6 months ago - ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025 - GlobeNewsWire